Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.71 |
| ▸ | NPC1 | O15118 | 10/20 | 0.64 |
| ▸ | RAB9A | P51151 | 10/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 9/20 | 0.64 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.64 |
| ▸ | HSD17B10 | Q99714 | 6/20 | 0.64 |
| ▸ | TP53 | P04637 | 4/20 | 0.64 |
| ▸ | PKM | P14618 | 4/20 | 0.64 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.64 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.64 |
| ▸ | KDR | P35968 | 2/20 | 0.61 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.61 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.61 |
| ▸ | AURKA | O14965 | 1/20 | 0.57 |
| ▸ | CDK1 | P06493 | 1/20 | 0.57 |
| ▸ | CDK2 | P24941 | 1/20 | 0.57 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.57 |
| ▸ | GAA | P10253 | 2/20 | 0.56 |
| ▸ | HPGD | P15428 | 6/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28633752 | 0.80 | KDR (0.56) | ESR1NPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL4497587 | 0.80 | TNKS (0.59) | ESR1NPC1RAB9AALDH1A1KDM4E | |
| SCHEMBL30561047 | 0.80 | NPC1 (1.00) | NPC1RAB9AALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL30634854 | 0.80 | NPC1 (1.00) | NPC1RAB9AALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL172216 | 0.80 | NPC1 (1.00) | NPC1RAB9AALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL27635441 | 0.78 | KDM4E (0.57) | NPC1RAB9AALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL4736411 | 0.78 | KDR (0.53) | ESR1NPC1RAB9AALDH1A1SMN1; SMN2 | |
| Water SCHEMBL9817804 | 0.78 | NPC1 (0.95) | NPC1RAB9AALDH1A1SMN1; SMN2KDM4E | |
| SCHEMBL29631691 | 0.77 | RAB9A (0.74) | ESR1NPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL374022 | 0.77 | RAB9A (0.74) | ESR1NPC1RAB9AALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115215839-B | Indolyl benzimidazole near-infrared fluorescent dye and preparation method and application thereof | 南京林业大学 | 2023-10-20 | — | — | CN | claimed |
| CN-115215839-A | Indolyl benzimidazole near-infrared fluorescent dye and preparation method and application thereof | 南京林业大学 | 2022-10-21 | — | — | CN | claimed |
| EP-1028120-B1 | Organosilicon compounds with N-substituted benzimidazole-benzazole or benzofuranyl-benzazole groups, sunscreen compositions containing these compounds and their use | OREAL (FR) | 2003-03-19 | — | — | EP | claimed |
| US-20020172647-A1 | Composition containing a steroid and a liposoluble UV filter | L'OREAL (FR) | 2002-11-21 | — | — | US | claimed |
| EP-1221933-A2 | COMPOSITION, ESPECIALLY A COSMETIC COMPOSITION, CONTAINING A STEROID AND A LIPOSOLUBLE UV FILTER | L'OREAL (FR) | 2002-07-17 | — | — | EP | claimed |
| US-6221343-B1 | Benzimidazole/benzofuryl-benzazole silicon compounds and UV-photoprotective compositions comprised thereof | SOCIETE L'OREAL S.A. (FR) | 2001-04-24 | — | — | US | claimed |
| WO-2001026618-A2 | COMPOSITION, ESPECIALLY A COSMETIC COMPOSITION, CONTAINING A STEROID AND A LIPOSOLUBLE UV FILTER | L'OREAL (FR) | 2001-04-19 | — | — | WO | claimed |
| EP-1028120-A1 | Organosilicon compounds with N-substituted benzimidazole-benzazole or benzofuranyl-benzazole groups, sunscreen compositions containing these compounds and their use | L'OREAL (FR) | 2000-08-16 | — | — | EP | claimed |
| EP-3709966-B1 | COMPOSITIONS COMPRISING AT LEAST ONE ACRYLIC POLYMER AND AT LEAST ONE INSOLUBLE ORGANIC SCREENING AGENT | OREAL (FR) | 2024-12-11 | — | — | EP | disclosed |
| EP-3700909-B1 | MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2024-01-24 | — | — | EP | disclosed |
| EP-2938324-B1 | LIQUID TOPICAL PHARMACEUTICAL NANO-EMULSION FORMULATIONS | JRX BIOTECHNOLOGY INC (US) | 2023-11-08 | — | — | EP | disclosed |
| CN-115215839-B | Indolyl benzimidazole near-infrared fluorescent dye and preparation method and application thereof | 南京林业大学 | 2023-10-20 | — | — | CN | disclosed |
| CN-115215839-B | Indolyl benzimidazole near-infrared fluorescent dye and preparation method and application thereof | 南京林业大学 | 2023-10-20 | — | — | CN | disclosed |
| CN-115215839-B | Indolyl benzimidazole near-infrared fluorescent dye and preparation method and application thereof | 南京林业大学 | 2023-10-20 | — | — | CN | disclosed |
| EP-1203789-A1 | Composition comprising a mixed silicate, polysacharide and crosslinked polymer and its utilisation | L'OREAL (FR) | 2002-05-08 | — | — | EP | disclosed |
| US-6221343-B1 | Benzimidazole/benzofuryl-benzazole silicon compounds and UV-photoprotective compositions comprised thereof | SOCIETE L'OREAL S.A. (FR) | 2001-04-24 | — | — | US | disclosed |
| WO-2001026618-A2 | COMPOSITION, ESPECIALLY A COSMETIC COMPOSITION, CONTAINING A STEROID AND A LIPOSOLUBLE UV FILTER | L'OREAL (FR) | 2001-04-19 | — | — | WO | disclosed |
| WO-2000078761-A1 | INDOLYL-BENZIMIDAZOLE ANTIBACTERIALS, AND METHODS OF USE THEREOF | SEPRACOR, INC. (US) | 2000-12-28 | — | — | WO | disclosed |
| EP-1028120-A1 | Organosilicon compounds with N-substituted benzimidazole-benzazole or benzofuranyl-benzazole groups, sunscreen compositions containing these compounds and their use | L'OREAL (FR) | 2000-08-16 | — | — | EP | disclosed |
| EP-1028120-A1 | Organosilicon compounds with N-substituted benzimidazole-benzazole or benzofuranyl-benzazole groups, sunscreen compositions containing these compounds and their use | L'OREAL (FR) | 2000-08-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020172647-A1 | Composition containing a steroid and a liposoluble UV filter | SHBG, GLA, LIPA | ESR1 2066/4885NPC1 1587/4885RAB9A 4027/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.